Alnylam Pharmaceuticals, Inc.
ALNY
ALNY: Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
moreShow ALNY Financials
Recent trades of ALNY by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ALNY's directors and management
Government lobbying spending instances
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$60,000 Jul 14, 2023 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Apr 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2023 Issue: Medicare/Medicaid
-
$100,000 Jan 14, 2023 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Oct 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Oct 16, 2022 Issue: None
-
$50,000 Jul 20, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2022 Issue: Health Issues Medicare/Medicaid
-
$60,000 Jul 15, 2022 Issue: None
-
$40,000 Jul 15, 2022 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid
-
$40,000 Apr 15, 2022 Issue: None
-
$40,000 Apr 14, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$60,000 Jan 20, 2022 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$40,000 Jan 13, 2022 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 15, 2021 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 14, 2021 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2021 Issue: Medicare/Medicaid Health Issues
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$40,000 Jul 13, 2021 Issue: Medicare/Medicaid
-
$50,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$60,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$30,000 Apr 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$40,000 Apr 12, 2021 Issue: Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 20, 2021 Issue: Medicare/Medicaid
-
$50,000 Jan 19, 2021 Issue: Medicare/Medicaid
-
$50,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 16, 2020 Issue: Medicare/Medicaid
-
$50,000 Oct 14, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 06, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$50,000 Jul 15, 2020 Issue: Medicare/Medicaid
-
$30,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 20, 2020 Issue: Medicare/Medicaid
-
$50,000 Apr 19, 2020 Issue: Medicare/Medicaid
-
$30,000 Apr 17, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Apr 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$50,000 Jan 21, 2020 Issue: Medicare/Medicaid
-
$60,000 Jan 17, 2020 Issue: Medicare/Medicaid
-
$30,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$50,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 21, 2019 Issue: Medicare/Medicaid
-
$20,000 Oct 21, 2019 Issue: Health Issues
-
$30,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jul 22, 2019 Issue: Health Issues
-
$50,000 Jul 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Jul 16, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$50,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Apr 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 22, 2019 Issue: Health Issues
-
$30,000 Jan 22, 2019 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2019 Issue: Health Issues
-
$40,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 22, 2018 Issue: Medicare/Medicaid
-
$30,000 Oct 22, 2018 Issue: Health Issues
-
$30,000 Oct 19, 2018 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2018 Issue: Health Issues
-
$30,000 Jul 19, 2018 Issue: Health Issues
-
$40,000 Apr 20, 2018 Issue: Health Issues
-
$30,000 Apr 20, 2018 Issue: Health Issues
-
$20,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Jan 22, 2018 Issue: Health Issues
-
$40,000 Oct 20, 2017 Issue: Health Issues
-
$40,000 Jul 20, 2017 Issue: Health Issues
-
$30,000 Jul 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues
-
$40,000 Apr 20, 2017 Issue: Health Issues
-
$40,000 Jan 23, 2017 Issue: Health Issues
-
$30,000 Jan 19, 2017 Issue: Medicare/Medicaid Health Issues
-
$40,000 Oct 26, 2016 Issue: Health Issues
-
$30,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues
-
$30,000 Jul 20, 2016 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2016 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 20, 2016 Issue: Health Issues Medicare/Medicaid
-
$50,000 Oct 20, 2015 Issue: Medicare/Medicaid Health Issues
New patents grants
Federal grants, loans, and purchases
Followers on ALNY's company Twitter account
Number of mentions of ALNY in WallStreetBets Daily Discussion
Recent insights relating to ALNY
Recent picks made for ALNY stock on CNBC
ETFs with the largest estimated holdings in ALNY
Flights by private jets registered to ALNY